These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 11973637

  • 1. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
    Wang D, Patil S, Li W, Humphrey LE, Brattain MG, Howell GM.
    Oncogene; 2002 Apr 25; 21(18):2785-96. PubMed ID: 11973637
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of TGFalpha autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor.
    Jiang D, Liang J, Humphrey LE, Yang H, Brattain MG.
    J Cell Physiol; 1998 May 25; 175(2):174-83. PubMed ID: 9525476
    [Abstract] [Full Text] [Related]

  • 4. The role of transforming growth factor alpha in determining growth factor independence.
    Awwad RA, Sergina N, Yang H, Ziober B, Willson JK, Zborowska E, Humphrey LE, Fan R, Ko TC, Brattain MG, Howell GM.
    Cancer Res; 2003 Aug 01; 63(15):4731-8. PubMed ID: 12907656
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells.
    Chen SC, Chou CK, Wong FH, Chang CM, Hu CP.
    Cancer Res; 1991 Apr 01; 51(7):1898-903. PubMed ID: 2004373
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.
    Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306
    [Abstract] [Full Text] [Related]

  • 13. Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-beta type RII receptor.
    Freeman JW, Mattingly CA, Strodel WE.
    J Cell Physiol; 1995 Oct 01; 165(1):155-63. PubMed ID: 7559796
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor.
    Burgaud JL, Baserga R.
    Exp Cell Res; 1996 Mar 15; 223(2):412-9. PubMed ID: 8601418
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP, Thomas H, Marks C, Green M, Fan Z, Modjtahedi H.
    Int J Oncol; 2008 Nov 15; 33(5):1107-13. PubMed ID: 18949375
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
    Wiepz GJ, Houtman JC, Cha D, Bertics PJ.
    J Cell Physiol; 1997 Oct 15; 173(1):44-53. PubMed ID: 9326448
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.